A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a).
Phase of Trial: Phase I/II
Latest Information Update: 19 Feb 2015
Price : $35 *
At a glance
- Drugs Obicetrapib (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- Sponsors Xention
- 15 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Nov 2014 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 21 Jan 2014 New trial record